|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.33 USD | +1.97% |
|
+1.65% | +36.66% |
| 07/05 | Jazz Pharmaceuticals Delivered Strong Q1 on Broad-Based Portfolio Growth, RBC Says | MT |
| 06/05 | Deutsche Bank Lifts Jazz Pharmaceuticals Price Target to $250 From $229, Maintains Buy Rating | MT |
| Capitalization | 14.58B 12.45B 11.41B 10.78B 19.97B 1,395B 20.07B 136B 52.87B 662B 54.7B 53.55B 2,301B | P/E ratio 2026 * |
15.4x | P/E ratio 2027 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise value | 16.28B 13.9B 12.73B 12.04B 22.29B 1,558B 22.41B 152B 59.03B 739B 61.07B 59.79B 2,569B | EV / Sales 2026 * |
3.62x | EV / Sales 2027 * | 3.03x |
| Free-Float |
96.72% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | +1.97% | ||
| 1 week | +1.65% | ||
| Current month | +14.44% | ||
| 1 month | +18.95% | ||
| 3 months | +39.70% | ||
| 6 months | +63.95% | ||
| Current year | +36.66% |
| 1 week | 221.29 |  | 235 |
| 1 month | 194.77 | | 235 |
| Current year | 156.95 | | 235 |
| 1 year | 103.6 | | 235 |
| 3 years | 95.49 | | 235 |
| 5 years | 95.49 | | 235 |
| 10 years | 86.88 | | 235 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 11/08/2025 |
Philip Johnson
DFI | Director of Finance/CFO | 61 | 01/03/2024 |
Liz Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 25/10/2019 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 18/01/2012 |
Rick Winningham
BRD | Director/Board Member | 66 | 01/01/2010 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.97% | +1.65% | +125.76% | +71.18% | 14.3B | |
| +2.61% | +2.91% | +36.15% | +133.81% | 883B | |
| +2.75% | +2.58% | +55.23% | +43.31% | 540B | |
| +0.31% | +1.69% | +10.90% | +41.69% | 367B | |
| -0.94% | -2.05% | +21.74% | +10.73% | 328B | |
| +0.13% | +1.47% | +35.23% | +14.62% | 288B | |
| +0.78% | +1.00% | +29.63% | +26.23% | 283B | |
| +0.96% | -0.10% | +48.05% | -3.15% | 278B | |
| +0.91% | +2.12% | -31.78% | -49.10% | 206B | |
| +0.05% | +1.61% | +24.40% | +44.43% | 181B | |
| Average | +0.73% | +1.41% | +35.53% | +33.38% | 336.8B | |
| Weighted average by Cap. | +0.70% | +1.43% | +30.99% | +50.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.5B 3.84B 3.52B 3.33B 6.16B 430B 6.19B 41.9B 16.31B 204B 16.87B 16.52B 710B | 4.82B 4.12B 3.77B 3.57B 6.6B 461B 6.64B 44.92B 17.49B 219B 18.09B 17.71B 761B |
| Net income | 1.02B 873M 800M 756M 1.4B 97.8B 1.41B 9.52B 3.71B 46.41B 3.83B 3.75B 161B | 1.03B 883M 809M 765M 1.42B 98.94B 1.42B 9.63B 3.75B 46.95B 3.88B 3.8B 163B |
| Net Debt | 1.7B 1.45B 1.33B 1.26B 2.33B 163B 2.34B 15.82B 6.16B 77.13B 6.37B 6.24B 268B | 15.43M 13.18M 12.07M 11.41M 21.13M 1.48B 21.24M 144M 55.96M 701M 57.89M 56.68M 2.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/26 | 232.33 $ | +1.97% | 918,040 |
| 12/05/26 | 227.84 $ | +1.89% | 807,834 |
| 11/05/26 | 223.61 $ | -0.97% | 997,701 |
| 08/05/26 | 225.79 $ | -0.52% | 741,275 |
| 07/05/26 | 226.96 $ | -0.70% | 1,129,460 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition